Martine A. Rothblatt serves as Chairperson & CEO of UNITED THERAPEUTICS Corp (UTHR). Rothblatt has also held reporting roles at BETA Technologies, Inc. (BETA). Rothblatt has reported 161 insider filings with the SEC since 2025. The most recent filing was in August 2026.
Every role Martine A. Rothblatt has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
UNITED THERAPEUTICS Corp (UTHR)60 filingsBETA Technologies, Inc. (BETA)1 filingUpdated Aug 30, 2026
Martine A. Rothblatt is Chairperson & CEO, Director of UNITED THERAPEUTICS Corp (UTHR). 149 SEC Form 4 filings on record going back to 2025, most recently on 28 August 2026. Most recent open-market trade: sold $64K of UTHR on 28 August 2026. Lifetime open-market purchases: $864K. Lifetime open-market sales: $702.51M.
Every recent SEC Form 4 transaction Martine A. Rothblatt has reported, most recent first.
InsiderAlpha's records for Martine A. Rothblatt go back to 2025: 149 primary Form 4 filings, an average of 74.5 per year. The typical open-market purchase is $864K (1 buy totaling $864K). The largest single buy on record is $864K of UTHR in 2026. Sales side: 1442 recorded sales totaling $702.51M, so the filing history runs sell-heavy by dollar value. 1737 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Martine A. Rothblatt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Martine A. Rothblatt is a corporate insider, tracked as Chairperson & CEO, Director of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 149 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
61 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 1 open-market purchase ($864K) and 1442 open-market sales ($702.51M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial